Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human immunoglobulin

EU orphan designation number: EU/3/03/169
Active ingredient: Human immunoglobulin
Indication: Treatment of dermatomyositis
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, F-31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2003 Centralised Orphan - Designation EMEA/OD/038/03 (2003)3969 of 20/10/2003
30/05/2011 Other procedure EMEA/OD/038/03
30/09/2013 Other procedure